Prevalence of Chronic Hepatitis B and Hepatitis C among First Time Blood Donors in Northeast Bosnia and Herzegovina: An Estimate of Prevalence in General Population

被引:12
作者
Petrovic, Jasminka [2 ]
Salkic, Nermin N. [1 ]
Ahmetagic, Sead [2 ]
Stojic, Vildana [2 ]
Mott-Divkovic, Slavica [3 ]
机构
[1] Univ Clin Ctr Tuzla, Dept Gastroenterol & Hepatol, Trnovac Bb 75000, Tuzla, Bosnia & Herceg
[2] Univ Clin Ctr Tuzla, Dept Infect Dis, Trnovac Bb 75000, Tuzla, Bosnia & Herceg
[3] Univ Clin Ctr Tuzla, Dept Transfus Med, Trnovac Bb 75000, Tuzla, Bosnia & Herceg
关键词
Hepatitis B; Hepatitis C virus; Epidemiology; Blood donors; Population; Bosnia and Herzegovina; HEALTH-CARE WORKERS; VIRUS-INFECTION; HBV; TRANSFUSION; HCV; RISK; ENGLAND; BURDEN; HIV;
D O I
10.5812/kowsar.1735143X.1506
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Data on the epidemiology of hepatitis B and C in Bosnia and Herzegovina (B&H) are lacking. Objectives:To assess the prevalence of hepatitis B surface antigen (HBsAg)and anti-hepatitis C virus (anti-HCV) in blood samples of first time blood donors in a well-defined region of B&H Our secondary goal was to estimate the prevalence of HBsAg and anti-HCV in the general population of the same region. Patients and Methods: We evaluated 8196 blood samples for the presence of HBsAg and/or anti-HCV, adjusted for differences in gender, and used the ratio estimation method to determine the prevalence in-the general population. Results: We analyzed 1263 (15.4%) female and 6933 (84.6%) male blood donors (male-to-female ratio: 5.49 to 1). The adjusted prevalence of HBsAg among blood donors was 0.787% (95% CI = 0.535-1.038), while the prevalence of anti-HCV was 0.267% (95% CI = 0.016-0.519). There was no difference in the prevalence of HBsAg or anti-HCV between men and women. We estimate that the prevalence of HBsAg and anti-HCV in the general population is 1.057% to 1.535% and 0.29% to 0.89%, respectively. Conclusions: The prevalence of HBsAg and anti-HCV among blood donors suggests that our region has low endemicity for both hepatitis B and hepatitis C. (C) 2011 Kowsar M.P.Co. All rights reserved.
引用
收藏
页码:629 / 633
页数:5
相关论文
共 25 条
[1]  
Acar A, 2010, BRAZ J INFECT DIS, V14, P41, DOI 10.1590/S1413-86702010000100009
[2]  
Ahmetagic Sead, 2006, Med Arh, V60, P298
[3]  
Ahmetagic Sead, 2009, Bosn J Basic Med Sci, V9, P278
[4]  
Ahmetagic Sead, 2006, Bosn J Basic Med Sci, V6, P13
[5]  
Batham A, 2007, INDIAN PEDIATR, V44, P663
[6]  
Bhattacharya P, 2007, WORLD J GASTROENTERO, V13, P3730
[7]  
Breslow N E, 1987, IARC Sci Publ, P1
[8]   SUMMARIZING INDICES FOR COMPARISON OF CANCER INCIDENCE DATA [J].
DOLL, R ;
COOK, P .
INTERNATIONAL JOURNAL OF CANCER, 1967, 2 (03) :269-&
[9]  
Durro V, 2010, CLIN LAB, V56, P591
[10]   Prevalence of HBV and HCV among blood donors in Kosovo [J].
Fejza, Hajrullah ;
Telaku, Skender .
VIROLOGY JOURNAL, 2009, 6